On the 24th, GI Biome, an affiliate of GI Innovation led by CEO Kim Young-Seok, announced its strategic move to target hospitals and clinics for the sales expansion of the probiotic product 'Number Seven (#7).'

GI Biome has initiated this endeavor by establishing its brand space on BluePharm Korea, the leading specialized pharmaceutical platform for hospitals and clinics operated by BlueMTec, a pharmaceutical e-commerce company. The company has commenced product sales through this platform and plans to actively pursue marketing targeting healthcare professionals, utilizing a dedicated Brand Manager (BM) for Number Seven to enhance sales promotion.

Read more: https://n.news.naver.com/mnews/article/030/0003148632?sid=102